Trial intelligence / Profile preview

TAP Block in Anterior Lumbar Arthrodesis

NCT06002217Completed

Sponsor
Clinique Saint-Jean
Start
Feb 2024
Primary completion
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms), sponsored by Clinique Saint-Jean. Primary endpoint: Analgesic consumption at 72 hours. Started Feb 2024; status: completed.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06002217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06002217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call